Tracking and curating putative SARS-CoV-2 recombinants with RIVET
Bioinformatics · 2023
DOI: 10.1093/bioinformatics/btad538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2023. Verfasst von Kyle Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of California, San Diego, San Diego, CA 92093, United States. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Motivation Identifying and tracking recombinant strains of SARS-CoV-2 is critical to understanding the evolution of the virus and controlling its spread. But confidently identifying SARS-CoV-2 recombinants from thousands of new genome sequences that are being shared online every day is quite challenging, causing many recombinants to be missed or suffer from weeks of delay in being formally identified while undergoing expert curation. Results We present RIVET—a software pipeline and visual platform that takes advantage of recent algorithmic advances in recombination inference to comprehensively and sensitively search for potential SARS-CoV-2 recombinants and organize the relevant information in a web interface that would help greatly accelerate the process of identifying and tracking recombinants. Availability and implementation RIVET-based web interface displaying the most updated analysis of potential SARS-CoV-2 recombinants is available at https://rivet.ucsd.edu/. RIVET’s frontend and backend code is freely available under the MIT license at https://github.com/TurakhiaLab/rivet and the documentation for RIVET is available at https://turakhialab.github.io/rivet/. The inputs necessary for running RIVET’s backend workflow for SARS-CoV-2 are available through a public database maintained and updated daily by UCSC (https://hgdownload.soe.ucsc.edu/goldenPath/wuhCor1/UShER_SARS-CoV-2/).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biological Sciences, University of California, San Diego, San Diego, CA 92093, United States.
- Department of Electrical and Computer Engineering, University of California, San Diego, San Diego, CA 92093, United States.
ORCID-Profile: Yatish Turakhia
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Smith, K., Ye, C., & Turakhia, Y. (2023). Tracking and curating putative SARS-CoV-2 recombinants with RIVET. Bioinformatics. https://doi.org/10.1093/bioinformatics/btad538
Vancouver
Smith K, Ye C, Turakhia Y. Tracking and curating putative SARS-CoV-2 recombinants with RIVET. Bioinformatics. 2023. doi:10.1093/bioinformatics/btad538
BibTeX
@article{Smith2023,
author = {Smith, Kyle and Ye, Cheng and Turakhia, Yatish},
title = {Tracking and curating putative SARS-CoV-2 recombinants with RIVET},
journal = {Bioinformatics},
year = {2023},
doi = {10.1093/bioinformatics/btad538}
}
EUVIMED